5-68293835-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_181523.3(PIK3R1):c.1425+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_181523.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIK3R1 | NM_181523.3 | c.1425+1G>T | splice_donor_variant, intron_variant | Intron 11 of 15 | ENST00000521381.6 | NP_852664.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Immunodeficiency 36 Pathogenic:3
The variant is not observed in the gnomAD v2.1.1 dataset. Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function. Multiple pathogenic loss-of-function variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic (ClinVar ID: VCV000156008). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
PVS1, PM2, PP3, PP5 -
not provided Pathogenic:1
The c.1425+1G>T pathogenic variant in the PIK3R1 gene has been reported previously (reported as g.67589663G>C using genomic coordinates) in an individual with immune dysfunction including hypogammaglobulinemia and recurrent infections (Deau et al., 2014). This splice site variant destroys the canonical splice donor site in intron 11. Additionally, different nucleotide variants (1425+1G>C, c.1425+1G>A, c.1425+2T>A) affecting this same cannonical splice donor site have been reported in multiple patients with PIK3R1-related disorders (Deau et al., 2014; Lucas et al., 2014; di Fonte et al., 2016). In vitro analysis demonstrated that this splice site variant results in in-frame skipping of exon 11 (reported as exon 10 due to alternate nomenclature), and results in a less stable truncated protein which is expressed at lower levels than wild-type (Deau et al., 2014). Functional studies in transfected cells indicated that this variant increases PI3K signaling (Deau et al., 2014). The c.1425+1G>T variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.1425+1G>T as a pathogenic variant. -
SHORT syndrome;C3554689:Agammaglobulinemia 7, autosomal recessive;C4014934:Immunodeficiency 36 Pathogenic:1
This sequence change affects a donor splice site in intron 11 of the PIK3R1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with activated PI3K-delta syndrome (PMID: 25133428). In at least one individual the variant was observed to be de novo. This variant is also known as G-to-T mutation at g.67589663. ClinVar contains an entry for this variant (Variation ID: 156008). Studies have shown that disruption of this splice site results in skipping of exon 11 (also known as exon 10 due to alternative exon numbering), but is expected to preserve the integrity of the reading-frame (PMID: 25133428). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at